MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study
(1)
,
(2)
,
(3)
,
(4)
,
(5)
,
(6)
,
(7)
,
(8)
,
(9)
,
(10)
,
(11)
,
(12)
,
(13)
,
(14)
,
(2)
,
(2)
,
(2)
,
(2)
,
(15)
,
(16)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
François Bertucci
- Function : Author
- PersonId : 753650
- IdHAL : francois-bertucci
- ORCID : 0000-0002-0157-0959
Mario Campone
- Function : Author
- PersonId : 761947
- ORCID : 0000-0002-5196-5908
Thomas Bachelot
- Function : Author
- PersonId : 757054
- ORCID : 0000-0002-0866-9484
Steven van Laere
- Function : Author
- PersonId : 779440
- ORCID : 0000-0003-2465-3252
Naoto Ueno
- Function : Author
- PersonId : 791524
- ORCID : 0000-0002-0166-7275
- IdRef : 185431739
Pascal Finetti
- Function : Author
- PersonId : 753338
- IdHAL : pascal-finetti
- ORCID : 0000-0002-2674-3123
Daniel Birnbaum
- Function : Author
- PersonId : 801231
- ORCID : 0000-0001-7920-9883
- IdRef : 092728782
Anthony Gonçalves
- Function : Author
- PersonId : 791165
- ORCID : 0000-0001-7570-7439